Cholangiocarcinoma presents a challenge for cancer specialists all over the world. Neoplasia of the biliary tract are rare, accounting for approximately 3% of all gastrointestinal tumours with an incidence of about 3 per 100,000; but rate have been rising rapidly in recent years. Thi cancer is one of the major killes. at the time of diagnosis less than 30% of patients are candidates for complete resection. For unresectable cholangiocarcinomas, median survival is less than 1 year. Given the rarity of the disease, the literature of cholangiocarcinoma is scant. However, the incrising incidence of the highly lethal malignancy should capture the attention of physicians and stimulate further research.
Brandi, G., Ercolani, G. (2015). Cholangiocarcinoma. New York : Nova Science Publisher, Inc..
Cholangiocarcinoma
BRANDI, GIOVANNI;ERCOLANI, GIORGIO
2015
Abstract
Cholangiocarcinoma presents a challenge for cancer specialists all over the world. Neoplasia of the biliary tract are rare, accounting for approximately 3% of all gastrointestinal tumours with an incidence of about 3 per 100,000; but rate have been rising rapidly in recent years. Thi cancer is one of the major killes. at the time of diagnosis less than 30% of patients are candidates for complete resection. For unresectable cholangiocarcinomas, median survival is less than 1 year. Given the rarity of the disease, the literature of cholangiocarcinoma is scant. However, the incrising incidence of the highly lethal malignancy should capture the attention of physicians and stimulate further research.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
